![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1556-7591|27|36|4-5
ISSN: 1042-1394
Source: ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol.27, Iss.36, 2015-09, pp. : 4-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
FDA approves OxyContin for certain pediatric patients
THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 1527-8395, Iss. 10, 2015-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Impact of abuse‐deterrent OxyContin on prescription opioid utilization
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Postmarketing Surveillance Study of OxyContin® Tablets for Relieving Moderate to Severe Cancer Pain
Oncology, Vol. 74, Iss. 1, 2008-08 ,pp. :